You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Androgenetic Alopecia: An Evidence-Based Treatment Update
|
|---|---|
| Published in |
American Journal of Clinical Dermatology, May 2014
|
| DOI | 10.1007/s40257-014-0077-5 |
| Pubmed ID | |
| Authors |
Supenya Varothai, Wilma F. Bergfeld |
| Abstract |
Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 320 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 320 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 47 | 15% |
| Student > Bachelor | 33 | 10% |
| Student > Postgraduate | 26 | 8% |
| Researcher | 25 | 8% |
| Student > Ph. D. Student | 25 | 8% |
| Other | 57 | 18% |
| Unknown | 107 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 117 | 37% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 7% |
| Biochemistry, Genetics and Molecular Biology | 17 | 5% |
| Agricultural and Biological Sciences | 16 | 5% |
| Nursing and Health Professions | 10 | 3% |
| Other | 24 | 8% |
| Unknown | 115 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2024.
All research outputs
#1,193,285
of 23,544,633 outputs
Outputs from American Journal of Clinical Dermatology
#57
of 1,001 outputs
Outputs of similar age
#12,377
of 227,900 outputs
Outputs of similar age from American Journal of Clinical Dermatology
#1
of 15 outputs
Altmetric has tracked 23,544,633 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,001 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,900 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.